IMU 5.08% 6.2¢ imugene limited

Analysts Reports (Imugene), page-236

  1. 3,056 Posts.
    lightbulb Created with Sketch. 1579
    Meanwhile...analyst from BP (Bell Potter) has downgraded Imugene valuation.

    From video - 21st September 2022...

    "Bell Potter has downgraded its price target on Imugene (ASX:IMU) to $0.36 per share from $0.45 and has a speculative buy rating on this stock. The price target downgrade follows Bell Potter identifying the need for the company to raise capital to support its clinical trial programs through the issuing of 400m new shares at $0.20 per share. Bell Potter also notes the company is executing quite a few trials over the next year where investors will be keeping a close eye on the results to determine just how valuable the company’s biotechnology operations are.

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
0.003(5.08%)
Mkt cap ! $455.6M
Open High Low Value Volume
5.8¢ 6.5¢ 5.7¢ $1.751M 28.44M

Buyers (Bids)

No. Vol. Price($)
6 660964 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 549788 5
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.